DK1121127T3 - Orale farmaceutiske sammensætninger, som indeholder buprenorphin - Google Patents

Orale farmaceutiske sammensætninger, som indeholder buprenorphin

Info

Publication number
DK1121127T3
DK1121127T3 DK99950690T DK99950690T DK1121127T3 DK 1121127 T3 DK1121127 T3 DK 1121127T3 DK 99950690 T DK99950690 T DK 99950690T DK 99950690 T DK99950690 T DK 99950690T DK 1121127 T3 DK1121127 T3 DK 1121127T3
Authority
DK
Denmark
Prior art keywords
oral pharmaceutical
pharmaceutical compositions
compositions containing
containing buprenorphine
pharmaceutically acceptable
Prior art date
Application number
DK99950690T
Other languages
English (en)
Inventor
Mauro Valenti
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Application granted granted Critical
Publication of DK1121127T3 publication Critical patent/DK1121127T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99950690T 1998-10-16 1999-10-11 Orale farmaceutiske sammensætninger, som indeholder buprenorphin DK1121127T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina
EP99950690A EP1121127B1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
PCT/EP1999/007595 WO2000023079A1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin

Publications (1)

Publication Number Publication Date
DK1121127T3 true DK1121127T3 (da) 2005-05-02

Family

ID=11380880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99950690T DK1121127T3 (da) 1998-10-16 1999-10-11 Orale farmaceutiske sammensætninger, som indeholder buprenorphin

Country Status (15)

Country Link
US (1) US6365596B1 (da)
EP (1) EP1121127B1 (da)
JP (1) JP2002527480A (da)
AT (1) ATE287264T1 (da)
AU (1) AU752449B2 (da)
CA (1) CA2347195C (da)
DE (1) DE69923336T2 (da)
DK (1) DK1121127T3 (da)
ES (1) ES2237165T3 (da)
HU (1) HU226166B1 (da)
IT (1) IT1302682B1 (da)
NZ (1) NZ511085A (da)
PT (1) PT1121127E (da)
SI (1) SI1121127T1 (da)
WO (1) WO2000023079A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1368023B1 (de) * 2001-02-16 2005-12-28 Grünenthal GmbH Verwendung von buprenorphin zur therapie der harninkontinenz
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
ATE412404T1 (de) * 2004-06-02 2008-11-15 Galephar M F Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
AU2006316607A1 (en) * 2005-11-21 2007-05-31 Schering-Plough Pty. Limited Pharmaceutical compositions comprising buprenorphine
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
US20090082383A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched buprenorphine
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
JP6210988B2 (ja) 2011-09-19 2017-10-11 オレクソ・アクチエボラゲット オピオイド依存を治療するための新規乱用耐性医薬組成物
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
DK3043777T3 (da) 2013-09-10 2020-07-20 Fresh Cut Dev Llc Sublingual buprenorphinspray
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016007245A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
WO2019144079A1 (en) 2018-01-22 2019-07-25 Yuhua Li Pharmaceutical composition for sustained release delivery of buprenorphine
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605671A (en) * 1984-09-28 1986-08-12 American Home Products Corporation Parenteral formulation
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JPH08295637A (ja) * 1995-04-27 1996-11-12 Green Cross Corp:The 口腔部局所投与剤
DE69709646T2 (de) * 1996-03-12 2002-08-14 Alza Corp., Palo Alto Zusammensetzung und dosisform mit einem opioid-antagonisten
JP3687025B2 (ja) * 1998-06-04 2005-08-24 東和薬品株式会社 安定なマレイン酸エナラプリル錠剤

Also Published As

Publication number Publication date
ITMI982222A0 (it) 1998-10-16
WO2000023079A1 (en) 2000-04-27
AU6337199A (en) 2000-05-08
ATE287264T1 (de) 2005-02-15
ITMI982222A1 (it) 2000-04-16
HUP0103924A2 (hu) 2002-02-28
US6365596B1 (en) 2002-04-02
HU226166B1 (en) 2008-05-28
CA2347195A1 (en) 2000-04-27
DE69923336D1 (de) 2005-02-24
SI1121127T1 (en) 2005-06-30
AU752449B2 (en) 2002-09-19
DE69923336T2 (de) 2005-05-25
EP1121127A1 (en) 2001-08-08
JP2002527480A (ja) 2002-08-27
IT1302682B1 (it) 2000-09-29
ES2237165T3 (es) 2005-07-16
EP1121127B1 (en) 2005-01-19
HUP0103924A3 (en) 2003-05-28
PT1121127E (pt) 2005-03-31
NZ511085A (en) 2002-10-25
CA2347195C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
AU7102201A (en) Propane-1,3-dione derivatives
ATE356625T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung enthaltend 5,8,14- triazatetracyclo (10.3.1.0(2,11) 0 (4,9) )- hexadeca-2(11) 3, 5,7, 9-pentaene
DE122008000001I1 (de) Orale Dosiszusammensetzungen mit verlängerter Freigabe
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
CA2366679A1 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
NO20013060D0 (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2003061572A8 (en) Anti-inflammatory formulations
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
AU2001242819A1 (en) Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof